QUOTE AND NEWS
TheStreet.com  Jan 26  Comment 
DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track big changes in volume activity. Often when above-average volume moves into an equity, it precedes a...
FiercePharma  Jan 26  Comment 
Novo Nordisk has set its Saxenda target and enlisted its U.S. sales force. Now it just needs to follow through--and that won't be an easy task.
MarketWatch  Jan 26  Comment 
Shares of Novo Nordisk gained 2.5% in premarket trade Monday after the drug manufacturer announced a new share buyback plan of up to 15 billion Danish Krone ($2.2 billion). Stock repurchases will be made over the next 12 months. Shares of...
MarketWatch  Jan 26  Comment 
Financial Times  Jan 25  Comment 
Danish pharmaceuticals group targets annual revenues of more than $1bn from Saxenda
FiercePharma  Jan 23  Comment 
Novo Nordisk's obesity therapy Saxenda is on a roll. Just over a month after snagging FDA approval, the drug scored a positive recommendation on Thursday from Europe's Committee for Medicinal Products for Human Use (CHMP). But by the time it gets...
The Hindu Business Line  Jan 19  Comment 
Denmark based pharmaceutical firm Novo Nordisk today launched its combination diabetic drug Ryzodeg, priced at Rs 1,595 for 300 units, for people with type II diabetes in India.Apart from I...
Financial Times  Dec 30  Comment 
US buyout group Apollo and China’s Fosun could also enter running as deadline looms





You may also be interested in articles related to Novo Nordisk A/S (NVO):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki